NeoGenomics, Inc. , a leading provider of oncology diagnostic solutions that enable precision medicine, and Ultima Genomics, Inc., a developer of a revolutionary ultra-high throughput
PacBio to leverage Chris’ extensive expertise in diagnostics and laboratory testing markets, as Board Member David Meline steps down. PacBio, a leading developer of high-quality,
ConcertAI and NeoGenomics announce a joint AI SaaS solution in hematological malignancies for research analytics, clinical trial design, and clinical trial operational optimization. CTO-H provides a research
Fuel up with free Health Tech Insights
